Clinical Trial: Evaluation of the Clinical Impact of Adjunctive L-carnitine Therapy in Critically Ill Hepatic Patients Admitted to Intensive Care Unit

U.S., June 12 -- ClinicalTrials.gov registry received information related to the study (NCT07642076) titled 'Evaluation of the Clinical Impact of Adjunctive L-carnitine Therapy in Critically Ill Hepatic Patients Admitted to Intensive Care Unit' on June 02.

Brief Summary: This study aims to evaluate the possible efficacy of l-carnitine in critically ill hepatic patients admitted to intensive care unit.

Study Start Date: June, 2026

Study Type: INTERVENTIONAL

Condition: Hepatic

Intervention: DRUG: L Carnitine

L-Carnitine, a natural substance present in the body, is essential for energy metabolism in mammals. l-carnitine presents as a drug.

DRUG: Standard medical treatment

Standard medical treatment for hepatic patient admitted to icu...